Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Therapeutic development in MASH: From accelerated approval to cirrhosis trial innovation
Med (New York, N.Y.);7(6):101172
Reparative Outcomes in Corneal Infection: Linking Adjunctive Tβ4 Treatment to Nerve Regeneration and Visual Function
Investigative ophthalmology & visual science;67(6):22
Drug-induced gastric motility disorders: A disproportionality analysis from the FAERS and CVARD databases
PloS one, 2026;21(6):e0351731
Re: Liu et al.: Rate and risk of nonarteritic anterior ischemic optic neuropathy with semaglutide use for diabetes and weight loss: a systematic review and meta-analysis (Ophthalmology 2026;133;589-598)
Ophthalmology, 2026
Improvement of Refractory Restless Legs Syndrome in a Parkinson’s Disease Patient After Semaglutide Treatment: A Novel Clinical Observation
Journal of movement disorders, 2026
Evidence-informed guidance for the clinical use of oral semaglutide in obesity management
Postgraduate medicine, 2026;:1-11
Boerhaave’s syndrome associated with glucagon-like peptide-1 receptor agonist use: a case report
Journal of cardiothoracic surgery, 2026
Impact of Preoperative Semaglutide Discontinuation Timing on Postoperative Outcomes in Aesthetic Abdominoplasty: A Retrospective Comparative Study
Aesthetic plastic surgery, 2026
Real-world and computational identification of herbal candidates associated with adverse event patterns in glucagon-like peptide-1 therapy for obesity
Scientific reports, 2026
Late-stage generation of 14C/3H-radiolabeled lysine residues via hydroformylation of peptides
Nature communications, 2026
Sustained Glycaemic Control and Preserved Beta-Cell Function in Newly Diagnosed Type 1 Diabetes Treated With Semaglutide
Diabetes/metabolism research and reviews;42(5):e70191
Towards Sustainable Synthesis of Peptide Therapeutics via Tag-Assisted Peptide Synthesis and Aryl Selenoester Aminolysis Ligation
Journal of the American Chemical Society, 2026
GLP-1-based therapy and ICD-10-documented heart failure or respiratory failure events in non-diabetic adults with rheumatoid arthritis and obesity: a TriNetX federated cohort study
Clinical rheumatology, 2026
Clinical evidence of semaglutide for metabolic dysfunction-associated steatotic liver disease (MASLD): An updated meta-analysis
British journal of clinical pharmacology, 2026
Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity
Arthritis & rheumatology (Hoboken, N.J.), 2026
[Pharmacological treatment of obstructive sleep apnea syndrome]
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova;126(5. Vyp. 2):48-54
SGLT2 inhibitors and incretin-based therapies for metabolic dysfunction-associated steatohepatitis: a systematic review
European journal of clinical pharmacology, 2026;82(7)
GLP-1 receptor agonist adjunct therapy stabilises Ramadan dysglycaemia in insulin-treated diabetes: a CGM-based study
Diabetes research and clinical practice, 2026;:113369
Cost-effectiveness of semaglutide versus dulaglutide for Type 2 Diabetes in China: A Markov Model analysis
PloS one, 2026;21(6):e0351059
Cross-sectional analysis of the reliability and engagement metrics of YouTube videos on semaglutide for weight loss
Medicine;105(23):e49173